PROGNOSTIC SIGNIFICANCE OF IHC BIOMARKERS FOR ASSESSING THE SURVIVAL OF PATIENTS WITH LUMINAL B BREAST CANCER WITHOUT HER2/NEU OVEREXPRESSION IN POSTMENOPAUSAL WOMEN
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.